Polyrizon Ltd. (NASDAQ:PLRZ) Short Interest Update

Polyrizon Ltd. (NASDAQ:PLRZ) was the target of a significant growth in short interest in April. As of April 15th, there was short interest totaling 67,203 shares, a growth of 94.3% from the March 31st total of 34,582 shares. Currently, 4.0% of the shares of the stock are short sold. Based on an average daily volume of 46,214 shares, the short-interest ratio is presently 1.5 days.

Polyrizon Stock Up 5.2%

NASDAQ:PLRZ traded up $0.77 during trading hours on Friday, reaching $15.56. 64,014 shares of the stock were exchanged, compared to its average volume of 54,280. The business has a 50-day moving average of $13.00 and a two-hundred day moving average of $10.64. Polyrizon has a twelve month low of $2.88 and a twelve month high of $2,235.00.

Polyrizon (NASDAQ:PLRZ) last released its quarterly earnings results on Saturday, February 14th. The company reported ($2.81) EPS for the quarter.

Analysts Set New Price Targets

PLRZ has been the subject of several analyst reports. Weiss Ratings reiterated a “sell (e+)” rating on shares of Polyrizon in a research report on Thursday, January 22nd. Wall Street Zen lowered Polyrizon from a “hold” rating to a “sell” rating in a research report on Saturday, March 28th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock currently has a consensus rating of “Sell”.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Polyrizon stock. Jane Street Group LLC purchased a new position in shares of Polyrizon Ltd. (NASDAQ:PLRZ) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 14,032 shares of the company’s stock, valued at approximately $119,000. Jane Street Group LLC owned approximately 1.35% of Polyrizon as of its most recent SEC filing.

Polyrizon Company Profile

Polyrizon Ltd. is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. is based in Raanana, Israel.